Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Journal of Immunology

• Publication date

  1976-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1082894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Supressor cells in the graft vs host reaction.

  1973cited by this paper
• ACTIVE SUPPRESSION OF IMMUNOGLOBULIN ALLOTYPE SYNTHESIS

  1973cited by this paper
• SYNERGY AMONG LYMPHOID CELLS MEDIATING THE GRAFT-VERSUS-HOST RESPONSE

  1973cited by this paper
• Depression of the T Cell Phenomenon of Contact Sensitivity by T Cells from Unresponsive Mice

  1973cited by this paper
• REGULATION OF THE ANTIBODY RESPONSE TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE

  1973cited by this paper
• SYNERGY DURING IN VITRO CYTOTOXIC ALLOGRAFT RESPONSES

  1973cited by this paper
• Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.

  1973cited by this paper
• Mechanism of allograft rejection in New Zealand mice. I. Cell synergy and its age-dependent loss.

  1973cited by this paper
• Role of the thymus in tolerance. X. "Suppressor" activity of antigen-stimulated rat thymocytes transferred to normal recipients.

  1973cited by this paper
• SYNERGY AMONG LYMPHOID CELLS MEDIATING THE GRAFT-VERSUS-HOST RESPONSE

  1972cited by this paper
• Enhanced immune responsiveness to a thymus‐independent antigen early after adult thymectomy: Evidence for short‐lived inhibitory thymus‐derived cells

  1972cited by this paper
• Variable effects of anti-lymphocyte serum on humoral antibody formation: role of thymus dependency of antigen.

  1971cited by this paper
• Kinetic Differences in Unresponsiveness of Thymus and Bone Marrow Cells

  1971cited by this paper
• Infectious immunological tolerance.

  1971cited by this paper
• Specific binding of antigen to lymphocytes. Evidence for lack of unispecificity in antigen-binding cells.

  1971cited by this paper
• Regulation of homocytotropic antibody formation in the rat. VI. Inhibitory effect of thymocytes on the homocytotropic antibody response.

  1971cited by this paper
• Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity.

  1970cited by this paper
• Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells.

  1970cited by this paper
• CARRIER FUNCTION IN ANTI-HAPTEN IMMUNE RESPONSES

  1970cited by this paper
• Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum.

  1970cited by this paper
• The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives.

  1970cited by this paper
• Antigen-Binding Cells in Normal Mouse Thymus

  1970cited by this paper
• Immunosuppressive agents, with special reference to antilymphocytic serum

  1969cited by this paper
• CELL TO CELL INTERACTION IN THE IMMUNE RESPONSE

  1968cited by this paper
• Time-dependent Immunosuppressive Effects of Anti-thymocyte Serum

  1967cited by this paper
• Thymus-Marrow Cell Combinations. Synergism in Antibody Production.∗

  1966cited by this paper
• The route of re-circulation of lymphocytes in the rat

  1964cited by this paper
• THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES

  1964cited by this paper
• Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

  1960cited by this paper
• Immunity to methylcholanthrene-induced sarcomas.

  1957cited by this paper
• Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin.

  1953cited by this paper

• Foxp3 Post-translational Modifications and Treg Suppressive Activity

  2019cites this paper
• Regulatory T Cells in Gynecologic Cancer.

  2018cites this paper
• Regulatory T Cells in Colorectal Cancer

  2018cites this paper
• Ontogeny of Tumor-associated CD4+CD25+Foxp3+ T-regulatory Cells

  2016cites this paper
• Pillars article: Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes. J. Exp. Med. 1981. 154: 952-963.

  2013cites this paper
• Suppression, subversion and escape: the role of regulatory T cells in cancer progression

  2013cites this paper
• How Numbers, Nature, and Immune Status of Foxp3+ Regulatory T-Cells Shape the Early Immunological Events in Tumor Development

  2013cites this paper
• to in Vitro Activation Bearer Spleen Cells by Depletion of Glass-adherent Cells Prior Augmentation of Antitumor Cytotoxicity in MOPC-315 Tumor

  2013cites this paper
• ChemoImmunoModulation: Focus on Myeloid Regulatory Cells

  2013cites this paper
• ChemoImmunoModulation: immune regulation by the antineoplastic chemotherapeutic agents.

  2012cites this paper
• Head and Neck Oncology

  2011influential citation
• Regulatory T Cells in Colorectal Cancer: From Biology to Prognostic Relevance

  2011cites this paper
• T Regulatory Cells – Friends or Foes?

  2010cites this paper
• – Friends or Foes ?

  2010cites this paper
• Evaluation of immunological status in tumor-bearing dogs.

  2009influential citation
• Establishment of combined immuno-chemotherapy with systemically administered gemcitabine and intra-portal administration of interleukin-2 in murine models of liver metastases of pancreatic cancer.

  2008cites this paper
• Representation of T cell functions in liver bearing hepatocellular carcinoma

  2008cites this paper
• Strategies for exploiting the immune system to achieve prevention and improve therapy of cancer

  2007cites this paper
• Cell Cytotoxicity Surgical Stress-mediated Suppression of Murine Natural Killer Updated Version

  2006cites this paper
• IN V N O SPLENIC IRRADIATION ERADICATES SUPPRESSOR AND INHIBITION OF ESTABLISHED TUMOR T-CELLS CAUSING THE REGRESSION

  2006cites this paper
• FOXP3 ensembles in T‐cell regulation

  2006cites this paper
• The role of the spleen in tumor bearing host: I. Characterization of spleen cells in tumor-bearing mice

  2006cites this paper
• CELLS FROM CHEMICALLY INDUCED MOUSE SARCOMAS DURING PROLONGED PASSAGE IN VITRO

  2006cites this paper
• Effect of Progressive Neoplastia Growth on the Decarboxylation of DL-[ 1-14 C ] Ornithineby Lymphocytes from C 3 H / He Tumor Hosts 1

  2006cites this paper
• An Inhibitorof LymphocyteProliferationProducedby a HumanColonic AdenocarcinomaCell Line in Culture1

  2006cites this paper
• ABROGATION OF THE IN VITRO GENERATION OF THE ROLE OF SUPPRESSOR CELLS THE CYTOTOXIC T-CELL RESPONSE TO A MURINE TUMOR:

  2006cites this paper
• Augmentation of Antitumor Cytotoxicity in MOPC-315 Tumor Bearer Spleen Cells by Depletion of Glass-adherent Cells Prior to in Vitro I

  2006cites this paper
• Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells.

  2005cites this paper
• Dietary restriction reduces the incidence of 3-methylcholanthrene-induced tumors in mice: Close correlation with its potentiating effect on host T cell functions

  2005cites this paper
• Chemotherapy, a double agent in respect of immune functions

  2004cites this paper
• Cytotoxic T lymphocytes in DBA/2 mice harboring L5178Y cells in a tumor-dormant state

  2004cites this paper
• The generation of tumor-specific in vivo protective immunity in the tumor mass from mice rendered tolerant to tumor antigens

  2004cites this paper
• Thymus function in patients with resectable lung carcinoma

  2004cites this paper
• Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules

  2004cites this paper
• Studies on the recovery from tolerance to tumor antigens

  2004cites this paper
• Reversal of defective lymphoproliferation in postoperative patients with colon cancer

  2004cites this paper
• Temporal changes of suppressor T lymphocytes and cytotoxic T lymphocytes in syngeneic murine malignant gliomas

  2004cites this paper
• Regulation of the immune response to antigens on the malignant cell surface

  2004cites this paper
• Tumor cell antigenicity, host immunity, and cancer metastasis

  2004cites this paper
• Plant lectin, ATF1011, on the tumor cell surface augments tumor-specific immunity through activation of T cells specific for the lectin

  2004cites this paper
• Suppressor and reactive lymphocytes in radiation leukemia virus (RadLV)-induced leukemogenesis

  2004cites this paper
• Two-color flow cytometric analysis of splenic lymphocyte subpopulations in patients with gastric cancer

  2004cites this paper
• Influence of progressive growth of a weakly immunogenic fibrosarcoma (T241) on the immune status of mice

  2004cites this paper
• Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2

  2004cites this paper
• Powered by the California Digital Library University of California ANIMALS BEARING MALIGNANT GRAFTS REJECT NORMAL GRAFTS THAT EXPRESS THROUGH GENE TRANSFER THE SAME ANTIGEN

  2003cites this paper
• Mechanisms of peripheral immune tolerance

  2003cites this paper
• Generation of Antigen-specific Suppressor Cells as a Consequence of Anti-I-A Antibody Treatment In Vivo

  2003cites this paper
• Human CD4+ CD25+ regulatory T cells suppress NKT cell functions.

  2003cites this paper
• Clinical development of the STn-KLH vaccine (Theratope).

  2003cites this paper
• Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: implications for autoimmunity and tumor immunity.

  2001cites this paper
• Vom Labor zur Klinik: vollsynthetische Antitumor‐Impfstoffe auf Kohlenhydratbasis

  2000cites this paper
• Tumor‐specific CD4+ suppressor T‐cell clone capable of inhibiting rejection of syngeneic sarcoma in A/J mice

  2000cites this paper
• Cancer Immunity: A Problem of Self-Tolerance

  2000cites this paper
• Breaking Immunological Tolerance to Tumor Cells as a Novel Immunotherapy for Cancer

  2000cites this paper
• Cancer regression induced by modified CTL therapy is regulated by HLA class II and class I antigens in Japanese patients with advanced cancer.

  2000cites this paper
• Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

  1999cites this paper
• Inhibitory effect of oral administration of Lactobacillus casei on 3-methylcholanthrene-induced carcinogenesis in mice

  1999cites this paper
• B cell-mediated down-regulation of IFN-gamma and IL-12 production induced during anti-tumor immune responses in the tumor-bearing state.

  1998cites this paper
• Vaccination with activated B cells pulsed with tumor-lysates can induce tumor-specific CD4+ T cells in vivo.

  1998cites this paper
• Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.

  1996cites this paper
• [Immunoregulation of murine mammary tumor growth].

  1996cites this paper
• Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.

  1996cites this paper
• Suppression of Tumour‐Specific Cytotoxic T‐Cell Responses Against the Syngeneic BALB/c Plasmacytoma ADJ‐PC‐5 by Tumour‐Induced CD8+ Regulatory T Cells Via IFN‐γ

  1996cites this paper
• (1→3)-β-d-Glucans as biological response modifiers: a review of structure-functional activity relationships

  1995cites this paper
• Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma.

  1995cites this paper
• Regulatory mechanisms of antitumor T cell responses in the tumor-bearing state

  1995cites this paper
• T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity

  1995cites this paper
• Peritoneal and splenic macrophage functions in the tumor-bearing host.

  1995cites this paper
• Do Structural Changes of T Cell Receptor Complex Occur in Tumor‐bearing State?

  1995cites this paper
• Fc gamma receptors in malignancies: friends or enemies?

  1994cites this paper
• Effects of non-MHC background genes on the induction of CD4+ T cells that prevent rejection of a highly immunogenic tumor, FBL-3.

  1994cites this paper
• Progression mechanisms in colon cancer: soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlations

  1994cites this paper
• Modulation of immune function and weight loss by L‐arginine in obstructive jaundice in the rat

  1994cites this paper
• Reconstitution of Anti‐tumor Effects of Lentinan in Nude Mice: Roles of Delayed‐type Hypersensitivity Reaction Triggered by CD4‐positive T Cell Clone in the Infiltration of Effector Cells into Tumor

  1994cites this paper
• Fcγ Receptors in Malignancies: Friends or Enemies?

  1994cites this paper
• Regression of rectal polyps by indomethacin suppository in familial adenomatous polyposis

  1994cites this paper
• Possible anti-tumor effects of drug-induced splenectomy with cyclophosphamide and indomethacin, and surgical splenectomy in combination with immunochemotherapy in tumor-bearing mice and gastric cancer patients

  1994cites this paper
• Selfish cells in altruistic cell society - a theoretical oncology.

  1993cites this paper
• Possible role of suppressor cells in the low effectiveness of adoptive immunotherapy for human cancers.

  1993cites this paper
• Successful therapy to a progressive tumor using monoclonal-antibodies to T-cell regulatory molecules and interleukin-2.

  1993cites this paper
• Observations on the treatment of autochthonous tumors in mice with an enterovirus and cyclophosphamide.

  1993cites this paper
• Myth of tumor immunology (review).

  1993cites this paper
• Suppression of Anti‐tumor CD4+ T Cell Responsiveness in the Tumor‐bearing State and Its Recovery in in vitro Culture Free of Tumor Burden

  1993cites this paper
• Transforming Growth Factor‐β CD4+ T cells Tumor‐bearing state Immunosuppression Enhanced Production of TGF‐β and a Progressive Increase in TGF‐β Susceptibility of Anti‐tumor CD4+ T Cell Function

  1993cites this paper
• Therapeutic Efficacy of a Tumor-Infiltrating Lymphocyte Clone in Combination with Soluble Tumor-Specific Transplantation Antigen and Cyclophosphamide

  1993cites this paper
• Autologous melanoma vaccine induces inflammatory responses in melanoma metastases: relevance to immunologic regression and immunotherapy.

  1993cites this paper
• Progressive splenomegaly with increasing extramedullary haematopoiesis in subcutaneous 9L-glioma bearing rats.

  1993cites this paper
• Tumors and aging: the influence of age-associated immune changes upon tumor growth and spread.

  1993cites this paper
• Immunotherapy with a tumor-infiltrating lymphocyte clone, soluble antigen, and cyclophosphamide.

  1992cites this paper
• Anti-Tumor Cell-Mediated Immune Reaction Following Local Hyperthermia Combined With Radiation In Mice

  1992cites this paper
• Local immunity and metastasis of colorectal carcinoma

  1992cites this paper
• Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity.

  1992cites this paper
• Explanations for reduced tumor proliferative capacity with age.

  1992cites this paper
• Effect of splenectomy and immuno-potentiator on tumor-bearing mice

  1992cites this paper
• Cancer Immunotherapy: Preclinical Studies with Triazene Compounds

  1992cites this paper
• Characterization of suppressor T cell clones derived from a mouse tolerized with conjugates of ovalbumin and monomethoxypolyethylene glycol.

  1992cites this paper
• Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.

  1992cites this paper
• Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA).

  1991cites this paper
• Immunotherapeutic elimination of syngeneic tumors in vivo by cytotoxic T lymphocytes generated in vitro from lymphocytes from the draining lymph nodes of tumor‐bearing mice

  1991cites this paper
• The influence of immunosenescence on tumor growth and spread: lessons from animal models.

  1991cites this paper